Navigation Links
23andMe announces agreement with Pfizer to research inflammatory bowel disease
Date:8/12/2014

Mountain View, Calif. August 12, 2014 23andMe, the leading personal genetics company today announced an agreement with Pfizer Inc. in which the companies will aim to enroll 10,000 people with Inflammatory Bowel Disease (IBD) in a research initiative designed to explore the genetic factors associated with the onset, progression, severity and response to treatments for IBD.

Approximately 1.4 million people in the U.S. alone suffer from IBD, according to estimates from the Centers for Disease Control and Prevention (CDC). While IBD is known to be more common in developed countries, the exact cause of this chronic illness is still unknown and there is no cure.

The collaboration represents an innovative effort for both companies designed to explore the underlying genetics of IBD and it is hoped that the effort will ultimately lead to potential new or improved treatments for IBD.

"We are excited to team up with Pfizer to take an innovative, consumer-centered approach to try to understand the fundamentals of inflammatory bowel disease and the variability of treatment response," said 23andMe CEO and Co-Founder Anne Wojcicki.

"Pfizer is committed to bringing forward new treatments for patients suffering with IBD," said Jose Carlos Gutierrez-Ramos, Senior Vice President, Biotherapeutics Research and Development, Pfizer. "By enhancing our understanding of the underlying biology of the disease, we hope to better support our clinical research activities and development programs."

All study participants will receive 23andMe's Personal Genome Service at no cost, including their ancestry analysis and uninterpreted raw genetic data. 23andMe will recruit individuals who are not current 23andMe customers and have also been diagnosed with Crohn's disease or ulcerative colitis by a qualified physician. Study participants will need to consent to provide a DNA sample (saliva), answer online surveys, and agree to share their data with researchers. The study is currently open to U.S. residents only.


'/>"/>

Contact: Jackie Kahn
Jackie.Kahn@edelman.com
202-538-0128
23andMe
Source:Eurekalert

Related biology news :

1. 23andMe identifies 5 significant genetic associations for hypothyroidism
2. 23andMe contributes to genetic discoveries related to male pattern baldness
3. 23andMe opens its API to developers
4. 23andMe Names Christine Castro, Neil Rothstein and Jonathan Ward to Leadership Positions
5. 23andMe scientists receive more than $500,000 in National Institutes of Health funding
6. 23andMes Ancestry Composition reveals peoples ancestral origins going back 500+ years
7. 23andMe identifies multiple genetic factors impacting development of nearsightedness
8. 23andMe and ALSPAC identify 16 new genetic associations for pollen, dust-mite and cat allergies
9. 23andMe conducts the first genetic study of non-syndromic striae distensae (stretch marks)
10. 23andMe helps identify 11 new genetic associations for asthma-with-hay fever
11. 23andMe scientists receive approximately $1.4 million in funding from National Institutes of Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... 23, 2017  Hunova, the first robotic gym for the rehabilitation and ... launched in Genoa, Italy . The first 30 robots ... the USA . The technology was developed and patented ... the IIT spin-off Movendo Technology thanks to a 10 million euro investment ... please click: ...
(Date:4/19/2017)... , April 19, 2017 ... its vendor landscape is marked by the presence of ... is however held by five major players - 3M ... these companies accounted for nearly 61% of the global ... leading companies in the global military biometrics market boast ...
(Date:4/11/2017)... BEACH GARDENS, Fla. , April 11, 2017 ... identity management and secure authentication solutions, today announced ... contract by Intelligence Advanced Research Projects Activity (IARPA) ... for IARPA,s Thor program. "Innovation has ... onset and IARPA,s Thor program will allow us ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... States multicenter, prospective clinical study that demonstrates the accuracy of the FebriDx® ... identifying clinically significant acute bacterial and viral respiratory tract infections by testing ...
(Date:10/11/2017)... N.C. (PRWEB) , ... October 11, 2017 , ... ... ARCS® Foundation President Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, ... ( ASTER Labs ), Inc. has been selected for membership in ARCS ...
(Date:10/11/2017)... BALTIMORE, Md. (PRWEB) , ... October 11, 2017 ... ... for digital pathology, announced today it will be hosting a Webinar titled, “Pathology ... of  Advanced Pathology Associates , on digital pathology adoption best practices and how ...
(Date:10/11/2017)... ... October 11, 2017 , ... A ... pregnancy rates in frozen and fresh in vitro fertilization (IVF) transfer ... age to IVF success. , After comparing the results from the fresh and ...
Breaking Biology Technology: